Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Mol Cell Biol
2000 Dec 01;2023:9041-54. doi: 10.1128/MCB.20.23.9041-9054.2000.
Show Gene links
Show Anatomy links
Transforming growth factor beta-independent shuttling of Smad4 between the cytoplasm and nucleus.
Pierreux CE
,
Nicolás FJ
,
Hill CS
.
???displayArticle.abstract??? Smad4 plays a pivotal role in all transforming growth factor beta (TGF-beta) signaling pathways. Here we describe six widely expressed alternatively spliced variants of human Smad4 with deletions of different exons in the linker, the region of Smad4 that separates the two well-conserved MH1 and MH2 domains. All these Smad4 variants form complexes with activated Smad2 and Smad3 and are incorporated into DNA-binding complexes with the transcription factor Fast-1, regardless of the amount of linker they contain. However, sequences encoded by exons 5 to 7 in the linker are essential for transcriptional activation. Most importantly, our observation that different Smad4 isoforms have different subcellular localizations has led us to the identification of a functional CRM1-dependent nuclear export signal in the Smad4 linker and a constitutively active nuclear localization signal in the N-terminal MH1 domain. In the absence of TGF-beta signaling, we conclude that Smad4 is rapidly and continuously shuttling between the nucleus and the cytoplasm, the distribution of Smad4 between the nucleus and the cytoplasm being dictated by the relative strengths of the nuclear import and export signals. We demonstrate that inhibition of CRM1-mediated nuclear export by treatment of cells with leptomycin B results in endogenous Smad4 accumulating very rapidly in the nucleus. Endogenous Smad2 and Smad3 are completely unaffected by leptomycin B treatment, indicating that the nucleocytoplasmic shuttling is specific for Smad4. We propose that, upon TGF-beta signaling, complex formation between Smad4 and activated Smad2 or -3 leads to nuclear accumulation of Smad4 through inhibition of its nuclear export. We demonstrate that after prolonged TGF-beta signaling Smad2 becomes dephosphorylated and Smad2 and Smad4 accumulate back in the cytoplasm.
Chen,
Nuclear trafficking of Cubitus interruptus in the transcriptional regulation of Hedgehog target gene expression.
1999, Pubmed
Chen,
Nuclear trafficking of Cubitus interruptus in the transcriptional regulation of Hedgehog target gene expression.
1999,
Pubmed
Chen,
A transcriptional partner for MAD proteins in TGF-beta signalling.
1996,
Pubmed
,
Xenbase
Chen,
Smad4 and FAST-1 in the assembly of activin-responsive factor.
1997,
Pubmed
,
Xenbase
Dingwall,
Nuclear targeting sequences--a consensus?
1991,
Pubmed
Dong,
Microtubule binding to Smads may regulate TGF beta activity.
2000,
Pubmed
Enoch,
Activation of the human beta-interferon gene requires an interferon-inducible factor.
1986,
Pubmed
Germain,
Homeodomain and winged-helix transcription factors recruit activated Smads to distinct promoter elements via a common Smad interaction motif.
2000,
Pubmed
,
Xenbase
Gorelik,
Abrogation of TGFbeta signaling in T cells leads to spontaneous T cell differentiation and autoimmune disease.
2000,
Pubmed
Görlich,
Transport between the cell nucleus and the cytoplasm.
1999,
Pubmed
Hahn,
DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1.
1996,
Pubmed
Hata,
OAZ uses distinct DNA- and protein-binding zinc fingers in separate BMP-Smad and Olf signaling pathways.
2000,
Pubmed
,
Xenbase
Hata,
Mutations increasing autoinhibition inactivate tumour suppressors Smad2 and Smad4.
1997,
Pubmed
,
Xenbase
Heldin,
SMAD destruction turns off signalling.
1999,
Pubmed
Hill,
The Rho family GTPases RhoA, Rac1, and CDC42Hs regulate transcriptional activation by SRF.
1995,
Pubmed
Howell,
Xenopus Smad4beta is the co-Smad component of developmentally regulated transcription factor complexes responsible for induction of early mesodermal genes.
1999,
Pubmed
,
Xenbase
Huang,
Identification of a potential regulator of early transcriptional responses to mesoderm inducers in the frog embryo.
1995,
Pubmed
,
Xenbase
Jensen,
mRNA profiling of rat islet tumors reveals nkx 6.1 as a beta-cell-specific homeodomain transcription factor.
1996,
Pubmed
Johnson,
An N-terminal nuclear export signal is required for the nucleocytoplasmic shuttling of IkappaBalpha.
1999,
Pubmed
Jonk,
Identification and functional characterization of a Smad binding element (SBE) in the JunB promoter that acts as a transforming growth factor-beta, activin, and bone morphogenetic protein-inducible enhancer.
1998,
Pubmed
Kaffman,
Regulation of nuclear localization: a key to a door.
1999,
Pubmed
Kageyama,
DPC4 splice variants in neuroblastoma.
1998,
Pubmed
Kretzschmar,
Opposing BMP and EGF signalling pathways converge on the TGF-beta family mediator Smad1.
1997,
Pubmed
Kretzschmar,
A mechanism of repression of TGFbeta/ Smad signaling by oncogenic Ras.
1999,
Pubmed
Liu,
Dual role of the Smad4/DPC4 tumor suppressor in TGFbeta-inducible transcriptional complexes.
1997,
Pubmed
,
Xenbase
Lo,
Ubiquitin-dependent degradation of TGF-beta-activated smad2.
1999,
Pubmed
Massagué,
Transcriptional control by the TGF-beta/Smad signaling system.
2000,
Pubmed
Massagué,
TGF-beta signal transduction.
1998,
Pubmed
Masuyama,
Identification of two Smad4 proteins in Xenopus. Their common and distinct properties.
1999,
Pubmed
,
Xenbase
Nakao,
TGF-beta receptor-mediated signalling through Smad2, Smad3 and Smad4.
1997,
Pubmed
,
Xenbase
Nigg,
Nucleocytoplasmic transport: signals, mechanisms and regulation.
1997,
Pubmed
Nishi,
Leptomycin B targets a regulatory cascade of crm1, a fission yeast nuclear protein, involved in control of higher order chromosome structure and gene expression.
1994,
Pubmed
Patterson,
The DAF-3 Smad protein antagonizes TGF-beta-related receptor signaling in the Caenorhabditis elegans dauer pathway.
1997,
Pubmed
Schutte,
DPC4 gene in various tumor types.
1996,
Pubmed
Sotiropoulos,
Signal-regulated activation of serum response factor is mediated by changes in actin dynamics.
1999,
Pubmed
Stroschein,
Negative feedback regulation of TGF-beta signaling by the SnoN oncoprotein.
1999,
Pubmed
Sun,
SnoN and Ski protooncoproteins are rapidly degraded in response to transforming growth factor beta signaling.
1999,
Pubmed
Tsukazaki,
SARA, a FYVE domain protein that recruits Smad2 to the TGFbeta receptor.
1998,
Pubmed
,
Xenbase
Tsukita,
Cortical actin organization: lessons from ERM (ezrin/radixin/moesin) proteins.
1999,
Pubmed
Whitman,
Smads and early developmental signaling by the TGFbeta superfamily.
1998,
Pubmed
Wieser,
GS domain mutations that constitutively activate T beta R-I, the downstream signaling component in the TGF-beta receptor complex.
1995,
Pubmed
Wong,
Smad3-Smad4 and AP-1 complexes synergize in transcriptional activation of the c-Jun promoter by transforming growth factor beta.
1999,
Pubmed
Wu,
Heteromeric and homomeric interactions correlate with signaling activity and functional cooperativity of Smad3 and Smad4/DPC4.
1997,
Pubmed
Xiao,
Importin beta mediates nuclear translocation of Smad 3.
2000,
Pubmed
Yagi,
Alternatively spliced variant of Smad2 lacking exon 3. Comparison with wild-type Smad2 and Smad3.
1999,
Pubmed
,
Xenbase
Zhu,
A SMAD ubiquitin ligase targets the BMP pathway and affects embryonic pattern formation.
1999,
Pubmed
,
Xenbase
de Caestecker,
The Smad4 activation domain (SAD) is a proline-rich, p300-dependent transcriptional activation domain.
2000,
Pubmed
de Caestecker,
Characterization of functional domains within Smad4/DPC4.
1997,
Pubmed
de Winter,
DPC4 (SMAD4) mediates transforming growth factor-beta1 (TGF-beta1) induced growth inhibition and transcriptional response in breast tumour cells.
1997,
Pubmed
ten Dijke,
Signaling inputs converge on nuclear effectors in TGF-beta signaling.
2000,
Pubmed
van Hengel,
Nuclear localization of the p120(ctn) Armadillo-like catenin is counteracted by a nuclear export signal and by E-cadherin expression.
1999,
Pubmed
